Madej et al., 2012 - Google Patents
Engineering of an anti‐epidermal growth factor receptor antibody to single chain format and labeling by sortase A‐mediated protein ligationMadej et al., 2012
- Document ID
- 17163428809054973573
- Author
- Madej M
- Coia G
- Williams C
- Caine J
- Pearce L
- Attwood R
- Bartone N
- Dolezal O
- Nisbet R
- Nuttall S
- Adams T
- Publication year
- Publication venue
- Biotechnology and bioengineering
External Links
Snippet
Sortase‐mediated protein ligation is a biological covalent conjugation system developed from the enzymatic cell wall display mechanism found in Staphylococcus aureus. This three‐ component system requires:(i) purified Sortase A (SrtA) enzyme;(ii) a substrate containing …
- 108090000250 Sortase A 0 title abstract description 50
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Madej et al. | Engineering of an anti‐epidermal growth factor receptor antibody to single chain format and labeling by sortase A‐mediated protein ligation | |
| US12324837B2 (en) | ROR1-specific antigen binding molecules | |
| AU2016225810B2 (en) | Modified Antibody Compositions, Methods of Making and Using Thereof | |
| EP3253795B1 (en) | Novel binding proteins comprising a ubiquitin mutein and antibodies or antibody fragments | |
| Stefan et al. | DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency | |
| US7655412B2 (en) | Self-assembly molecules | |
| Ho et al. | A novel high‐affinity human monoclonal antibody to mesothelin | |
| US20170275380A1 (en) | Detection of a polypeptide dimer by a bivalent binding agent | |
| Hudson et al. | Multiplex epitope mapping using bacterial surface display reveals both linear and conformational epitopes | |
| TWI661096B (en) | High-throughput screening of functional antibody fragments, immunoconjugate comprising the same, and adaptor-drug conjugate for screening | |
| Nilvebrant et al. | Selection and in vitro characterization of human CD44v6‐binding antibody fragments | |
| Könning et al. | Isolation of a pH-sensitive IgNAR variable domain from a yeast-displayed, histidine-doped master library | |
| EP4279508A1 (en) | Cd5-targeting fully humanized antibody | |
| Michigami et al. | A “ligand-targeting” peptide-drug conjugate: Targeted intracellular drug delivery by VEGF-binding helix-loop-helix peptides via receptor-mediated endocytosis | |
| Li et al. | Multivalent Rhamnose‐Modified EGFR‐Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies | |
| EP4392457A2 (en) | Bispecific tetravalent antibody targeting egfr and her3 | |
| KR20230159855A (en) | Multivalent proteins and screening methods | |
| Masuda et al. | AHNP-streptavidin: a tetrameric bacterially produced antibody surrogate fusion protein against p185her2/neu | |
| WO2024074762A1 (en) | Ultrastable antibody fragments with a novel disuldide bridge | |
| US20210395396A1 (en) | Her2-binding tetrameric polypeptides | |
| CN112823168A (en) | Tetrameric polypeptide that binds HER2 | |
| US20250108112A1 (en) | Methods of generating, stimulating, or increasing proliferation of different subsets of cd8+ t cells | |
| Badarinath et al. | A facile yeast-display approach for antibody mask discovery | |
| HK40051469A (en) | Her2-binding tetrameric polypeptides | |
| WO2022236095A1 (en) | Methods and compositions thereof for site-specific labeling of human igg by proximity-based sortase-mediated ligation |